Efficacy and safety of Programmed Death Ligand 1 inhibitors versus Programmed Death 1 inhibitors in the first-line treatment of advanced non-small cell lung cancer: a meta-analysis of randomized controlled trials.
来源：PubMed发布日期：2026-01-01作者：Dang C, Li J, Chen H, Luo Z0 次点击